Description
A naturally occuring purine derivative; an intermediate in the synthesis of uric acid; elevated in spinal fluid of patients with Lesch-Nyhan syndrome; increases succinate dehydrogenase and complex II activities and decreases cytochrome c oxidase activity, resulting in neuroenergetic impairment, ATP depletion, and cellular apoptosis in rat striatum; used to induce hyperuricemia in mice,
Formal name: 1,9-dihydro-6H-purin-6-one
Synonyms: 6-Hydroxypurine|NSC 129419|NSC 14665
Molecular weight: 136.1
CAS: 68-94-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory